Atrophic gastritis and the risk of incident colorectal cancer

Cancer Causes and Control

Volumn 21, Issue 1, 2010, Pages 163-170

  Laiyemo, Adeyinka O ^a   Kamangar, Farin ^a,b   Marcus, Pamela M ^a   Taylor, Philip R ^a   Virtamo, Jarmo ^c   Albanes, Demetrius ^a   Stolzenberg Solomon, Rachael Z ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MORGAN STATE UNIVERSITY   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Atrophic gastritis; Colorectal cancer; Serum pepsinogen

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; PEPSINOGEN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CIGARETTE SMOKING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FINLAND; GASTROSCOPY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SERUM; STOMACH CANCER;

AGED; COLORECTAL NEOPLASMS; GASTRITIS, ATROPHIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPSINOGEN A; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 74149083258     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9446-4     Document Type: Article

References (34)

1. KM Newbold 1989 Undifferentiated cells in gastrointestinal mucosa inferring an association between carcinoma of the colon and intestinal type gastric cancer J Clin Pathol 42 5 523 524 10.1136/jcp.42.5.523 16811174
2. M Jones P Helliwell C Pritchard J Tharakan J Mathew 2007 Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 12 5 51 10.1186/1477-7819-5-51
3. N Zumkeller H Brenner J Chang-Claude M Hoffmeister A Nieters D Rothenbacher 2007 Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany Eur J Cancer 43 8 1283 1289 10.1016/j.ejca.2007.03.005 1:CAS:528:DC%2BD2sXlt1ahsb0%3D 17446060 (Pubitemid 46720251)
4. A Machida-Montani S Sasazuki M Inoue, et al. 2007 Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study Helicobacter 12 4 328 332 10.1111/j.1523-5378.2007.00513.x 17669106 (Pubitemid 47196338)
5. PJ Limburg RZ Stolzenberg-Solomon LH Colbert, et al. 2002 Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers Cancer Epidemiol Biomarkers Prev 11 10 Pt 1 1095 1099 12376513
6. EJ Kuipers 2006 Proton pump inhibitors and gastric neoplasia Gut 55 9 1217 1221 10.1136/gut.2005.090514 1:CAS:528:DC%2BD28XhtVehurjL 16905689 (Pubitemid 44277346)
7. F Hollande A Imdahl T Mantamadiotis GD Ciccotosto A Shulkes GS Baldwin 1997 Glycine-extended gastrin acts as an autocrine growth factor in a non-transformed colon cell line Gastroenterology 113 1576 1588 10.1053/gast.1997.v113.pm9352860 1:CAS:528:DyaK2sXnt1Olt70%3D 9352860 (Pubitemid 27461244)
8. GD Ciccotosto A McLeish KJ Hardy A Shulkes 1995 Expression, processing, and secretion of gastrin in patients with colorectal carcinoma Gastroenterology 109 4 1142 1153 10.1016/0016-5085(95)90572-3 1:CAS:528:DyaK2MXos1aqtbw%3D 7557079
9. EM van Soest LG van Rossum JP Dieleman, et al. 2008 Proton pump inhibitors and the risk of colorectal cancer Am J Gastroenterol 103 4 966 973 10.1111/j.1572-0241.2007.01665.x 18070237
10. DJ Robertson H Larsson S Friis L Pedersen JA Baron HT Sørensen 2007 Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study Gastroenterology 133 3 755 760 10.1053/j.gastro.2007.06.014 17678921 (Pubitemid 47385871)
11. YX Yang S Hennessy K Propert WT Hwang A Sedarat JD Lewis 2007 Chronic proton pump inhibitor therapy and the risk of colorectal cancer Gastroenterology 133 3 748 754 10.1053/j.gastro.2007.06.022 1:CAS:528:DC%2BD2sXhtFarsrbJ 17678926 (Pubitemid 47374135)
12. PD Siersema S Yu P Sahbaie, et al. 2006 Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use Gastrointest Endosc 63 4 581 586 10.1016/j.gie.2005.08.043 16564855
13. JF Seitz M Giovannini J Gouvernet AP Gauthier 1991 Elevated serum gastrin levels in patients with colorectal neoplasia J Clin Gastroenterol 13 541 545 10.1097/00004836-199110000-00013 1:STN:280:DyaK38%2FnvVGqsw%3D%3D 1744390
14. JP Smith JG Wood TE Solomon 1989 Elevated gastrin levels in patients with colon cancer or adenomatous polyps Dig Dis Sci 34 171 174 10.1007/BF01536047 1:STN:280:DyaL1M7itVCktw%3D%3D 2914535 (Pubitemid 19068164)
15. K Wong K Beardshall CM Waters J Calam GJ Poston 1991 Postprandial hypergastrinaemia in patients with colorectal cancer Gut 32 1352 1354 10.1136/gut.32.11.1352 1:STN:280:DyaK38%2FptVOmuw%3D%3D 1752467
16. CM Thorburn GD Friedman CJ Dickinson JH Vogelman N Orentreich J Parsonnet 1998 Gastrin and colorectal cancer: a prospective study Gastroenterology 115 275 280 10.1016/S0016-5085(98)70193-3 1:STN:280:DyaK1czktl2rsg%3D%3D 9679032 (Pubitemid 28363419)
17. JW Kikendall AR Glass LH Sobin PE Bowen 1992 Serum gastrin is not higher in subjects with colonic neoplasia Am J Gastroenterol 87 1394 1397 1:STN:280:DyaK3s%2FjsFWktA%3D%3D 1415093
18. ID Penman E el-Omar JE Ardill, et al. 1994 Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection Gastroenterology 106 1263 1270 1:STN:280:DyaK2c3ivFCltA%3D%3D 8174887
19. R Yapp IM Modlin RR Kumar HJ Binder R Dubrow 1992 Gastrin and colorectal cancer. Evidence against an association Dig Dis Sci 37 481 484 10.1007/BF01307566 1:STN:280:DyaK383gtFSnsg%3D%3D 1551333
20. K Varis M Kekki M Harkonen P Sipponen IM Samloff 1991 Serum pepsinogen I and serum gastrin in screening of atrophic pangastritis with high risk of gastric cancer Scand J Gastroenterol Suppl 186 117 123 10.3109/00365529109103998 1:STN:280:DyaK387gtFSmsQ%3D%3D 1759119
21. K Yanaoka M Oka C Mukoubayashi, et al. 2008 Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males Cancer Epidemiol Biomarkers Prev 17 4 838 845 10.1158/1055-9965.EPI-07-2762 1:CAS:528:DC%2BD1cXkslGqtbo%3D 18398025
22. K Miki 2006 Gastric cancer screening using the serum pepsinogen test method Gastric Cancer 9 4 245 253 10.1007/s10120-006-0397-0 17235625 (Pubitemid 44846546)
23. ATBC Cancer Prevention Study Group 1994 The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study Ann Epidemiol 4 1 10
24. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group 1994 The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1029 1035 10.1056/NEJM199404143301501 (Pubitemid 24106559)
25. IM Samloff 1982 Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum Gastroenterology 82 1 26 33 1:CAS:528: DyaL38XmsVKhsg%3D%3D 7053333
26. K Varis PR Taylor P Sipponen, et al. 1998 The Helsinki gastritis study group. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and betacarotene Scand J Gastroenterol 33 294 300 10.1080/00365529850170892 1:CAS:528:DyaK1cXisVKmsrw%3D 9548624 (Pubitemid 28156921)
27. K Varis P Sipponen F Laxén, et al. 2000 The Helsinki gastritis study group. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia Scand J Gastroenterol 35 950 956 10.1080/003655200750023011 1:CAS:528:DC%2BD3cXntlShu7g%3D 11063155
28. AB Price 1991 The Sydney system: histological division J Gastroenterol Heptol 6 209 222 10.1111/j.1440-1746.1991.tb01468.x 1:STN:280: DyaK38%2FgtlCqsQ%3D%3D
29. P Korhonen N Malila E Pukkala L Teppo D Albanes J Virtamo 2002 The Finnish cancer registry as follow-up source of a large trial cohort: accuracy and delay Acta Oncol 41 381 388 10.1080/028418602760169442 12234031 (Pubitemid 34941123)
30. DJ Robertson RS Sandler DJ Ahnen, et al. 2009 Gastrin, Helicobacter pylori, and Colorectal Adenomas Clin Gastroenterol Hepatol 7 2 163 167 10.1016/j.cgh.2008.09.006 1:CAS:528:DC%2BD1MXjs1Kmt7s%3D 18929688
31. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide IARC CancerBase no. 5. version 2.0, IARC Press, Lyon. http://www-dep.iarc.fr/. Accessed 6 Jan 2009
32. JK Lee BJ Park KY Yoo YO Ahn 1995 Dietary factors and stomach cancer: a case-control study in Korea Int J Epidemiol 24 1 33 41 10.1093/ije/24.1.33 1:STN:280:DyaK2Mzhsl2isg%3D%3D 7797354
33. E Buiatti D Palli A Decarli, et al. 1989 A case-control study of gastric cancer and diet in Italy Int J Cancer 44 4 611 616 10.1002/ijc.2910440409 1:STN:280:DyaK3c%2FgslOntA%3D%3D 2793233
34. JM Ramón L Serra C Cerdó J Oromí 1993 Dietary factors and gastric cancer risk. A case-control study in Spain Cancer 71 5 1731 1735 10.1002/1097-0142(19930301)71:5<1731::AID-CNCR2820710505>3.0.CO;2-X 8448737 (Pubitemid 23067387)